Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 1
1981 1
1982 2
1984 3
1985 1
1986 1
1987 1
1988 8
1989 2
1990 4
1991 8
1992 10
1993 12
1994 5
1995 9
1996 9
1997 16
1998 8
1999 11
2000 18
2001 25
2002 23
2003 40
2004 55
2005 75
2006 89
2007 86
2008 111
2009 144
2010 146
2011 199
2012 213
2013 251
2014 278
2015 310
2016 401
2017 458
2018 506
2019 602
2020 778
2021 819
2022 488
Text availability
Article attribute
Article type
Publication date

Search Results

5,561 results
Results by year
Filters applied: . Clear all
Page 1
Advances in NK cell production.
Fang F, Xie S, Chen M, Li Y, Yue J, Ma J, Shu X, He Y, Xiao W, Tian Z. Fang F, et al. Among authors: tian z. Cell Mol Immunol. 2022 Apr;19(4):460-481. doi: 10.1038/s41423-021-00808-3. Epub 2022 Jan 5. Cell Mol Immunol. 2022. PMID: 34983953 Review.
Sestrin2 in atherosclerosis.
Tian Z, Yan BJ, Luo W, Gui DD, Zhou K, Tian KJ, Ma Y, Zhou ZX, Jiang ZS. Tian Z, et al. Clin Chim Acta. 2021 Dec;523:325-329. doi: 10.1016/j.cca.2021.10.019. Epub 2021 Oct 16. Clin Chim Acta. 2021. PMID: 34666031 Review.
YTHDF1 promotes mRNA degradation via YTHDF1-AGO2 interaction and phase separation.
Li J, Chen K, Dong X, Xu Y, Sun Q, Wang H, Chen Z, Liu C, Liu R, Yang Z, Mei X, Zhang R, Chang L, Tian Z, Chen J, Liang K, He C, Luo M. Li J, et al. Among authors: tian z. Cell Prolif. 2022 Jan;55(1):e13157. doi: 10.1111/cpr.13157. Epub 2021 Nov 25. Cell Prolif. 2022. PMID: 34821414 Free PMC article.
5,561 results